Katayama K, Ohtani H, Mizuno H, Taniguchi T, Kakemi M, Koizumi T
Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan.
J Pharmacobiodyn. 1990 Feb;13(2):120-9. doi: 10.1248/bpb1978.13.120.
The effect of tolbutamide (TB) on the urinary excretion of sulfamethizole (SMZ) under constant infusion of SMZ at 100 mg/h was studied. Intravenous administration of TB (50 mg/kg) caused a decrease in the urinary excretion rate of SMZ but an increase in the unbound concentration of SMZ in plasma. The total concentration of SMZ in plasma decreased rapidly after TB injection and then increased gradually to a level higher than the control. The slope of the terminal phase of the unbound concentration of TB in plasma in the presence of SMZ was significantly smaller than that of TB alone. The analysis using the perfusion limited model showed that the elimination kinetics of SMZ in the presence of TB could be described by the mutual displacement of plasma protein binding of both drugs and the competitive inhibition of the tubular secretion of SMZ by the unbound concentration of TB in renal vein. Further the inhibitor constant was in good agreement with that for the in vitro uptake by renal cortex slices.
研究了在以100mg/h的速度持续输注磺胺甲噻二唑(SMZ)的情况下,甲苯磺丁脲(TB)对SMZ尿排泄的影响。静脉注射TB(50mg/kg)导致SMZ的尿排泄率降低,但血浆中SMZ的游离浓度增加。注射TB后,血浆中SMZ的总浓度迅速下降,然后逐渐上升至高于对照的水平。在存在SMZ的情况下,血浆中TB游离浓度终末相的斜率明显小于单独使用TB时。使用灌注限制模型的分析表明,在存在TB的情况下,SMZ的消除动力学可以通过两种药物血浆蛋白结合的相互置换以及肾静脉中TB游离浓度对SMZ肾小管分泌的竞争性抑制来描述。此外,抑制剂常数与肾皮质切片体外摄取的抑制剂常数非常一致。